X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://ml-eu.globenewswire.com/Resource/Download/c4442fee-72fd-4922-b334-504a4ab313aa
https://www.prnewswire.com/news-releases/profoundbio-to-present-data-on-multiple-preclinical-programs-from-its-antibody-drug-conjugate-pipeline-at-the-american-association-for-cancer-research-annual-meeting-2024-302107496.html
https://endpts.com/profoundbio-founded-by-former-seagen-leaders-nabs-112m-for-four-clinical-stage-adcs/
https://www.prnewswire.com/news-releases/profoundbio-announces-first-patient-dosed-in-phase-12-clinical-trial-of-pro1107-a-protein-tyrosine-kinase-7-ptk7-targeted-antibody-drug-conjugate-incorporating-a-novel-proprietary-hydrophilic-mmae-based-linker-drug-302052878.html
https://www.prnewswire.com/news-releases/profoundbio-to-participate-in-upcoming-rbc-capital-markets-and-jp-morgan-healthcare-conferences-302005732.html
https://www.prnewswire.com/news-releases/profoundbio-announces-upcoming-scientific-presentations-at-sitc-2023-301941369.html
https://www.prnewswire.com/news-releases/profoundbio-announces-further-advancement-of-lead-programs---pro1184-rinatabart-sesutecan-and-pro1160-in-the-clinic-301835477.html
Market Place
Share 
